Parabilis Medicines, Inc.
PBLS
$38.76
-$1.01-2.54%
NASDAQ
| 06/30/2026 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 240.60% | -- | |||
| Total Receivables | -- | -- | |||
| Inventory | -- | -- | |||
| Prepaid Expenses | 54.93% | -- | |||
| Finance Division Loans and Leases Current | -- | -- | |||
| Total Finance Division Other Current Assets | -- | -- | |||
| Other Current Assets | -- | -- | |||
| Total Current Assets | 238.90% | -- | |||
|
|
|||||
| Total Current Assets | 238.90% | -- | |||
| Net Property, Plant & Equipment | -3.41% | -- | |||
| Long-term Investments | -- | -- | |||
| Goodwill | -- | -- | |||
| Total Other Intangibles | -- | -- | |||
| Finance Div Loans & Leases LT | -- | -- | |||
| Total Finance Div Other LT Assets | -- | -- | |||
| Total Other Assets | -9.04% | -- | |||
| Total Assets | 205.92% | -- | |||
|
|
|||||
| Total Accounts Payable | 23.19% | -- | |||
| Total Accrued Expenses | -12.32% | -- | |||
| Short-term Debt | -- | -- | |||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | |||
| Finance Division Debt Current | -19.86% | -- | |||
| Total Finance Division Other Current Liabilities | 195.89% | -- | |||
| Total Other Current Liabilities | 195.89% | -- | |||
| Total Current Liabilities | 15.85% | -- | |||
|
|
|||||
| Total Current Liabilities | 15.85% | -- | |||
| Long-Term Debt | -- | -- | |||
| Short-term Debt | -- | -- | |||
| Capital Leases | -6.08% | -- | |||
| Finance Division Debt Non Current | -- | -- | |||
| Total Finance Division Other Non Current Liabilities | -- | -- | |||
| Total Other Liabilities | -37.70% | -- | |||
| Total Liabilities | -8.88% | -- | |||
|
|
|||||
| Common Stock & APIC | 10,124.45% | -- | |||
| Retained Earnings | -8.94% | -- | |||
| Treasury Stock & Other | -- | -- | |||
| Total Common Equity | 283.71% | -- | |||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | |||
| Preferred Stock Non Redeemable | -- | -- | |||
| Preferred Stock Convertible | -- | -- | |||
| Preferred Stock, Others | -- | -- | |||
| Total Preferred Equity | -- | -- | |||
|
|
|||||
| Total Common Equity | 283.71% | -- | |||
| Total Preferred Equity | -- | -- | |||
| Total Minority Interest | -- | -- | |||
| Total Equity | 329.01% | -- | |||
|
|
|||||